|
Post by orlon on Mar 29, 2014 16:58:36 GMT -5
I've read a small portion of the FDA document and not being a science type don't fully understand the ins and outs of the trials. That said, I've also read the 'woe is me, we've been lied to by the company,' comments, as well as the 'I told you so' group. There's been two sides to this story, one by supported by Epstein(?) and George Rho, and the other by the doomsayers. The FDA BD raised issues and asked questions that need to be answered. The Company will be there to answer them. I don't see this as a one way street where the FDA's independent panel sits and scolds Mannkind for spending billions on a new therapy and wasting everyone's time. I see this as a discussion by professionals to see if this new therapy will benefit diabetics or not. Mannkind will certainly debate the promise of the therapy...and answer questions that need to be answered. This is a big moment for Mannkind and hopefully they will give it their best shot. My humble suggestion is this:Let's sit back, take a deep breath, and watch the joust on Tuesday.
|
|